APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Sufentanil Citrate Injection

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Sufentanil Citrate Injection Market Outlook and Growth Opportunities 2026

Report ID 174038330427 December 2025199 pages

Choose your research edition.

Industry ResearchSufentanil Citrate Injection Industry Research Report 2026126 pages · $2,950 USDIndustry Growth & TrendsGlobal Sufentanil Citrate Injection Industry Growth and Trends Forecast to 2032105 pages · $3,450 USDMarket StructureGlobal Sufentanil Citrate Injection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Sufentanil Citrate Injection Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Sufentanil Citrate Injection Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Sufentanil Citrate Injection market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Sufentanil Citrate Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Sufentanil Citrate Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Sufentanil Citrate Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Sufentanil Citrate Injection market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Sufentanil Citrate Injection market include Akorn, EuroCept B.V., hameln pharma gmbh, Hikma Pharmaceuticals USA, IDT Biologika GmBH, Pfizer, Piramal Critical Care Limited, Nhwa Pharmaceutical and Sinopharm, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Sufentanil Citrate Injection market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Sufentanil Citrate Injection and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Sufentanil Citrate Injection sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Sufentanil Citrate Injection market size, projected growth trends, production technologies, key applications, and end-use industries.

Sufentanil Citrate Injection Segment by Company

Akorn

EuroCept B.V.

hameln pharma gmbh

Hikma Pharmaceuticals USA

IDT Biologika GmBH

Pfizer

Piramal Critical Care Limited

Nhwa Pharmaceutical

Sinopharm

Humanwell Pharmaceutical

Sufentanil Citrate Injection Segment by Type

5ml

2ml

1ml

10ml

Sufentanil Citrate Injection Segment by Application

Hospital

Clinic

Others

Sufentanil Citrate Injection Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Sufentanil Citrate Injection status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Sufentanil Citrate Injection market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Sufentanil Citrate Injection significant trends, drivers, influence factors in global and regions.

6. To analyze Sufentanil Citrate Injection competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Sufentanil Citrate Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Sufentanil Citrate Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Sufentanil Citrate Injection.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Sufentanil Citrate Injection market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Sufentanil Citrate Injection industry.

Chapter 3: Detailed analysis of Sufentanil Citrate Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Sufentanil Citrate Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Sufentanil Citrate Injection in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Sufentanil Citrate Injection Industry Trends Table 2. Sufentanil Citrate Injection Industry Drivers Table 3. Sufentanil Citrate Injection Industry Opportunities and Challenges Table 4. Sufentanil Citrate Injection Industry Restraints Table 5. Global Sufentanil Citrate Injection Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Sufentanil Citrate Injection Revenue Share by Company (2021-2026) Table 7. Global Sufentanil Citrate Injection Sales Volume by Company (Units) & (2021-2026) Table 8. Global Sufentanil Citrate Injection Sales Volume Share by Company (2021-2026) Table 9. Global Sufentanil Citrate Injection Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Sufentanil Citrate Injection Company Ranking, (2024-2026) & (USD Million) Table 11. Global Sufentanil Citrate Injection Key Company Manufacturing Base & Headquarters Table 12. Global Sufentanil Citrate Injection Company, Product Type & Application Table 13. Global Sufentanil Citrate Injection Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Sufentanil Citrate Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of 5ml Table 18. Significant Companies of 2ml Table 19. Significant Companies of 1ml Table 20. Significant Companies of 10ml Table 21. Global Sufentanil Citrate Injection Sales Volume by Type 2021 VS 2025 VS 2032 (Units) Table 22. Global Sufentanil Citrate Injection Sales Volume by Type (2021-2026) & (Units) Table 23. Global Sufentanil Citrate Injection Sales Volume by Type (2027-2032) & (Units) Table 24. Global Sufentanil Citrate Injection Sales Volume Share by Type (2021-2026) Table 25. Global Sufentanil Citrate Injection Sales Volume Share by Type (2027-2032) Table 26. Global Sufentanil Citrate Injection Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Sufentanil Citrate Injection Sales Value by Type (2021-2026) & (US$ Million) Table 28. Global Sufentanil Citrate Injection Sales Value by Type (2027-2032) & (US$ Million) Table 29. Global Sufentanil Citrate Injection Sales Value Share by Type (2021-2026) Table 30. Global Sufentanil Citrate Injection Sales Value Share by Type (2027-2032) Table 31. Significant Companies of Hospital Table 32. Significant Companies of Clinic Table 33. Significant Companies of Others Table 34. Global Sufentanil Citrate Injection Sales Volume by Application 2021 VS 2025 VS 2032 (Units) Table 35. Global Sufentanil Citrate Injection Sales Volume by Application (2021-2026) & (Units) Table 36. Global Sufentanil Citrate Injection Sales Volume by Application (2027-2032) & (Units) Table 37. Global Sufentanil Citrate Injection Sales Volume Share by Application (2021-2026) Table 38. Global Sufentanil Citrate Injection Sales Volume Share by Application (2027-2032) Table 39. Global Sufentanil Citrate Injection Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 40. Global Sufentanil Citrate Injection Sales Value by Application (2021-2026) & (US$ Million) Table 41. Global Sufentanil Citrate Injection Sales Value by Application (2027-2032) & (US$ Million) Table 42. Global Sufentanil Citrate Injection Sales Value Share by Application (2021-2026) Table 43. Global Sufentanil Citrate Injection Sales Value Share by Application (2027-2032) Table 44. Global Sufentanil Citrate Injection Sales by Region: 2021 VS 2025 VS 2032 (Units) Table 45. Global Sufentanil Citrate Injection Sales by Region (2021-2026) & (Units) Table 46. Global Sufentanil Citrate Injection Sales Market Share by Region (2021-2026) Table 47. Global Sufentanil Citrate Injection Sales by Region (2027-2032) & (Units) Table 48. Global Sufentanil Citrate Injection Sales Market Share by Region (2027-2032) Table 49. Global Sufentanil Citrate Injection Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 50. Global Sufentanil Citrate Injection Sales Value by Region (2021-2026) & (US$ Million) Table 51. Global Sufentanil Citrate Injection Sales Value Share by Region (2021-2026) Table 52. Global Sufentanil Citrate Injection Sales Value by Region (2027-2032) & (US$ Million) Table 53. Global Sufentanil Citrate Injection Sales Value Share by Region (2027-2032) Table 54. Global Sufentanil Citrate Injection Market Average Price (US$/Unit) by Region (2021-2026) Table 55. Global Sufentanil Citrate Injection Market Average Price (US$/Unit) by Region (2027-2032) Table 56. Global Sufentanil Citrate Injection Sales by Country: 2021 VS 2025 VS 2032 (Units) Table 57. Global Sufentanil Citrate Injection Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 58. Global Sufentanil Citrate Injection Sales by Country (2021-2026) & (Units) Table 59. Global Sufentanil Citrate Injection Sales Market Share by Country (2021-2026) Table 60. Global Sufentanil Citrate Injection Sales by Country (2027-2032) & (Units) Table 61. Global Sufentanil Citrate Injection Sales Market Share by Country (2027-2032) Table 62. Global Sufentanil Citrate Injection Sales Value by Country (2021-2026) & (US$ Million) Table 63. Global Sufentanil Citrate Injection Sales Value Market Share by Country (2021-2026) Table 64. Global Sufentanil Citrate Injection Sales Value by Country (2027-2032) & (US$ Million) Table 65. Global Sufentanil Citrate Injection Sales Value Market Share by Country (2027-2032) Table 66. Akorn Company Information Table 67. Akorn Business Overview Table 68. Akorn Sufentanil Citrate Injection Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 69. Akorn Sufentanil Citrate Injection Product Portfolio Table 70. Akorn Recent Development Table 71. EuroCept B.V. Company Information Table 72. EuroCept B.V. Business Overview Table 73. EuroCept B.V. Sufentanil Citrate Injection Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. EuroCept B.V. Sufentanil Citrate Injection Product Portfolio Table 75. EuroCept B.V. Recent Development Table 76. hameln pharma gmbh Company Information Table 77. hameln pharma gmbh Business Overview Table 78. hameln pharma gmbh Sufentanil Citrate Injection Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. hameln pharma gmbh Sufentanil Citrate Injection Product Portfolio Table 80. hameln pharma gmbh Recent Development Table 81. Hikma Pharmaceuticals USA Company Information Table 82. Hikma Pharmaceuticals USA Business Overview Table 83. Hikma Pharmaceuticals USA Sufentanil Citrate Injection Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. Hikma Pharmaceuticals USA Sufentanil Citrate Injection Product Portfolio Table 85. Hikma Pharmaceuticals USA Recent Development Table 86. IDT Biologika GmBH Company Information Table 87. IDT Biologika GmBH Business Overview Table 88. IDT Biologika GmBH Sufentanil Citrate Injection Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. IDT Biologika GmBH Sufentanil Citrate Injection Product Portfolio Table 90. IDT Biologika GmBH Recent Development Table 91. Pfizer Company Information Table 92. Pfizer Business Overview Table 93. Pfizer Sufentanil Citrate Injection Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. Pfizer Sufentanil Citrate Injection Product Portfolio Table 95. Pfizer Recent Development Table 96. Piramal Critical Care Limited Company Information Table 97. Piramal Critical Care Limited Business Overview Table 98. Piramal Critical Care Limited Sufentanil Citrate Injection Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. Piramal Critical Care Limited Sufentanil Citrate Injection Product Portfolio Table 100. Piramal Critical Care Limited Recent Development Table 101. Nhwa Pharmaceutical Company Information Table 102. Nhwa Pharmaceutical Business Overview Table 103. Nhwa Pharmaceutical Sufentanil Citrate Injection Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 104. Nhwa Pharmaceutical Sufentanil Citrate Injection Product Portfolio Table 105. Nhwa Pharmaceutical Recent Development Table 106. Sinopharm Company Information Table 107. Sinopharm Business Overview Table 108. Sinopharm Sufentanil Citrate Injection Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 109. Sinopharm Sufentanil Citrate Injection Product Portfolio Table 110. Sinopharm Recent Development Table 111. Humanwell Pharmaceutical Company Information Table 112. Humanwell Pharmaceutical Business Overview Table 113. Humanwell Pharmaceutical Sufentanil Citrate Injection Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 114. Humanwell Pharmaceutical Sufentanil Citrate Injection Product Portfolio Table 115. Humanwell Pharmaceutical Recent Development Table 116. Key Raw Materials Table 117. Raw Materials Key Suppliers Table 118. Sufentanil Citrate Injection Distributors List Table 119. Sufentanil Citrate Injection Customers List Table 120. Research Programs/Design for This Report Table 121. Authors List of This Report Table 122. Secondary Sources Table 123. Primary Sources List of Figures Figure 1. Sufentanil Citrate Injection Product Image Figure 2. Global Sufentanil Citrate Injection Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Sufentanil Citrate Injection Sales Value (2021-2032) & (US$ Million) Figure 4. Global Sufentanil Citrate Injection Sales (2021-2032) & (Units) Figure 5. Global Sufentanil Citrate Injection Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Sufentanil Citrate Injection Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. 5ml Image Figure 10. 2ml Image Figure 11. 1ml Image Figure 12. 10ml Image Figure 13. Global Sufentanil Citrate Injection Sales Volume by Type (2021 VS 2025 VS 2032) & (Units) Figure 14. Global Sufentanil Citrate Injection Sales Volume Share 2021 VS 2025 VS 2032 Figure 15. Global Sufentanil Citrate Injection Sales Volume Share by Type (2021-2032) Figure 16. Global Sufentanil Citrate Injection Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Sufentanil Citrate Injection Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global Sufentanil Citrate Injection Sales Value Share by Type (2021-2032) Figure 19. Hospital Image Figure 20. Clinic Image Figure 21. Others Image Figure 22. Global Sufentanil Citrate Injection Sales Volume by Application (2021 VS 2025 VS 2032) & (Units) Figure 23. Global Sufentanil Citrate Injection Sales Volume Share 2021 VS 2025 VS 2032 Figure 24. Global Sufentanil Citrate Injection Sales Volume Share by Application (2021-2032) Figure 25. Global Sufentanil Citrate Injection Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 26. Global Sufentanil Citrate Injection Sales Value Share 2021 VS 2025 VS 2032 Figure 27. Global Sufentanil Citrate Injection Sales Value Share by Application (2021-2032) Figure 28. Global Sufentanil Citrate Injection Sales by Region: 2021 VS 2025 VS 2032 (Units) Figure 29. Global Sufentanil Citrate Injection Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 30. Global Sufentanil Citrate Injection Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 31. Global Sufentanil Citrate Injection Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 32. North America Sufentanil Citrate Injection Sales Value (2021-2032) & (US$ Million) Figure 33. North America Sufentanil Citrate Injection Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Europe Sufentanil Citrate Injection Sales Value (2021-2032) & (US$ Million) Figure 35. Europe Sufentanil Citrate Injection Sales Value Share by Country (%), 2025 VS 2032 Figure 36. Asia-Pacific Sufentanil Citrate Injection Sales Value (2021-2032) & (US$ Million) Figure 37. Asia-Pacific Sufentanil Citrate Injection Sales Value Share by Country (%), 2025 VS 2032 Figure 38. South America Sufentanil Citrate Injection Sales Value (2021-2032) & (US$ Million) Figure 39. South America Sufentanil Citrate Injection Sales Value Share by Country (%), 2025 VS 2032 Figure 40. Middle East & Africa Sufentanil Citrate Injection Sales Value (2021-2032) & (US$ Million) Figure 41. Middle East & Africa Sufentanil Citrate Injection Sales Value Share by Country (%), 2025 VS 2032 Figure 42. USA Sufentanil Citrate Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. USA Sufentanil Citrate Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. USA Sufentanil Citrate Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Canada Sufentanil Citrate Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Canada Sufentanil Citrate Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Canada Sufentanil Citrate Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Mexico Sufentanil Citrate Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Mexico Sufentanil Citrate Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Mexico Sufentanil Citrate Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Germany Sufentanil Citrate Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Germany Sufentanil Citrate Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Germany Sufentanil Citrate Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. France Sufentanil Citrate Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. France Sufentanil Citrate Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. France Sufentanil Citrate Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. U.K. Sufentanil Citrate Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. U.K. Sufentanil Citrate Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. U.K. Sufentanil Citrate Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Italy Sufentanil Citrate Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Italy Sufentanil Citrate Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Italy Sufentanil Citrate Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Spain Sufentanil Citrate Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Spain Sufentanil Citrate Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Spain Sufentanil Citrate Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Russia Sufentanil Citrate Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Russia Sufentanil Citrate Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Russia Sufentanil Citrate Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Netherlands Sufentanil Citrate Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Netherlands Sufentanil Citrate Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Netherlands Sufentanil Citrate Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. Nordic Countries Sufentanil Citrate Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. Nordic Countries Sufentanil Citrate Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. Nordic Countries Sufentanil Citrate Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. China Sufentanil Citrate Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. China Sufentanil Citrate Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. China Sufentanil Citrate Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Japan Sufentanil Citrate Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Japan Sufentanil Citrate Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Japan Sufentanil Citrate Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. South Korea Sufentanil Citrate Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. South Korea Sufentanil Citrate Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. South Korea Sufentanil Citrate Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. India Sufentanil Citrate Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. India Sufentanil Citrate Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. India Sufentanil Citrate Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Australia Sufentanil Citrate Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Australia Sufentanil Citrate Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Australia Sufentanil Citrate Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Southeast Asia Sufentanil Citrate Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Southeast Asia Sufentanil Citrate Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Southeast Asia Sufentanil Citrate Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Brazil Sufentanil Citrate Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Brazil Sufentanil Citrate Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Brazil Sufentanil Citrate Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Argentina Sufentanil Citrate Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Argentina Sufentanil Citrate Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Argentina Sufentanil Citrate Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Chile Sufentanil Citrate Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Chile Sufentanil Citrate Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Chile Sufentanil Citrate Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Colombia Sufentanil Citrate Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Colombia Sufentanil Citrate Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Colombia Sufentanil Citrate Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Peru Sufentanil Citrate Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Peru Sufentanil Citrate Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Peru Sufentanil Citrate Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Sufentanil Citrate Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Saudi Arabia Sufentanil Citrate Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Saudi Arabia Sufentanil Citrate Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Israel Sufentanil Citrate Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Israel Arabia Sufentanil Citrate Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Israel Arabia Sufentanil Citrate Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. UAE Sufentanil Citrate Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. UAE Sufentanil Citrate Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. UAE Sufentanil Citrate Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Turkey Sufentanil Citrate Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Turkey Sufentanil Citrate Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Turkey Sufentanil Citrate Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Iran Sufentanil Citrate Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Iran Sufentanil Citrate Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Iran Sufentanil Citrate Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Egypt Sufentanil Citrate Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 124. Egypt Sufentanil Citrate Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 125. Egypt Sufentanil Citrate Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 126. Sufentanil Citrate Injection Value Chain Figure 127. Manufacturing Cost Structure Figure 128. Sufentanil Citrate Injection Sales Mode & Process Figure 129. Direct Comparison with Distribution Share Figure 130. Distributors Profiles Figure 131. Years Considered Figure 132. Research Process Figure 133. Key Executives Interviewed

Scope & coverage.

Types
  • 5ml
  • 2ml
  • 1ml
  • 10ml
Applications
  • Hospital
  • Clinic
  • Others
Companies covered
  • Akorn
  • EuroCept B.V.
  • hameln pharma gmbh
  • Hikma Pharmaceuticals USA
  • IDT Biologika GmBH
  • Pfizer
  • Piramal Critical Care Limited
  • Nhwa Pharmaceutical
  • Sinopharm
  • Humanwell Pharmaceutical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Sufentanil Citrate Injection Sales Value (2021-2032)
  4. 1.2.2 Global Sufentanil Citrate Injection Sales Volume (2021-2032)
  5. 1.2.3 Global Sufentanil Citrate Injection Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Sufentanil Citrate Injection Market Dynamics
  1. 2.1 Sufentanil Citrate Injection Industry Trends
  2. 2.2 Sufentanil Citrate Injection Industry Drivers
  3. 2.3 Sufentanil Citrate Injection Industry Opportunities and Challenges
  4. 2.4 Sufentanil Citrate Injection Industry Restraints
3 Sufentanil Citrate Injection Market by Company
  1. 3.1 Global Sufentanil Citrate Injection Company Revenue Ranking in 2025
  2. 3.2 Global Sufentanil Citrate Injection Revenue by Company (2021-2026)
  3. 3.3 Global Sufentanil Citrate Injection Sales Volume by Company (2021-2026)
  4. 3.4 Global Sufentanil Citrate Injection Average Price by Company (2021-2026)
  5. 3.5 Global Sufentanil Citrate Injection Company Ranking (2024-2026)
  6. 3.6 Global Sufentanil Citrate Injection Company Manufacturing Base and Headquarters
  7. 3.7 Global Sufentanil Citrate Injection Company Product Type and Application
  8. 3.8 Global Sufentanil Citrate Injection Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Sufentanil Citrate Injection Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Sufentanil Citrate Injection Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Sufentanil Citrate Injection Market by Type
  1. 4.1 Sufentanil Citrate Injection Type Introduction
  2. 4.1.1 5ml
  3. 4.1.2 2ml
  4. 4.1.3 1ml
  5. 4.1.4 10ml
  6. 4.2 Global Sufentanil Citrate Injection Sales Volume by Type
  7. 4.2.1 Global Sufentanil Citrate Injection Sales Volume by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Sufentanil Citrate Injection Sales Volume by Type (2021-2032)
  9. 4.2.3 Global Sufentanil Citrate Injection Sales Volume Share by Type (2021-2032)
  10. 4.3 Global Sufentanil Citrate Injection Sales Value by Type
  11. 4.3.1 Global Sufentanil Citrate Injection Sales Value by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Sufentanil Citrate Injection Sales Value by Type (2021-2032)
  13. 4.3.3 Global Sufentanil Citrate Injection Sales Value Share by Type (2021-2032)
5 Sufentanil Citrate Injection Market by Application
  1. 5.1 Sufentanil Citrate Injection Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Others
  5. 5.2 Global Sufentanil Citrate Injection Sales Volume by Application
  6. 5.2.1 Global Sufentanil Citrate Injection Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Sufentanil Citrate Injection Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Sufentanil Citrate Injection Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Sufentanil Citrate Injection Sales Value by Application
  10. 5.3.1 Global Sufentanil Citrate Injection Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Sufentanil Citrate Injection Sales Value by Application (2021-2032)
  12. 5.3.3 Global Sufentanil Citrate Injection Sales Value Share by Application (2021-2032)
6 Sufentanil Citrate Injection Regional Sales and Value Analysis
  1. 6.1 Global Sufentanil Citrate Injection Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Sufentanil Citrate Injection Sales by Region (2021-2032)
  3. 6.2.1 Global Sufentanil Citrate Injection Sales by Region: 2021-2026
  4. 6.2.2 Global Sufentanil Citrate Injection Sales by Region (2027-2032)
  5. 6.3 Global Sufentanil Citrate Injection Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Sufentanil Citrate Injection Sales Value by Region (2021-2032)
  7. 6.4.1 Global Sufentanil Citrate Injection Sales Value by Region: 2021-2026
  8. 6.4.2 Global Sufentanil Citrate Injection Sales Value by Region (2027-2032)
  9. 6.5 Global Sufentanil Citrate Injection Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Sufentanil Citrate Injection Sales Value (2021-2032)
  12. 6.6.2 North America Sufentanil Citrate Injection Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Sufentanil Citrate Injection Sales Value (2021-2032)
  15. 6.7.2 Europe Sufentanil Citrate Injection Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Sufentanil Citrate Injection Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Sufentanil Citrate Injection Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Sufentanil Citrate Injection Sales Value (2021-2032)
  21. 6.9.2 South America Sufentanil Citrate Injection Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Sufentanil Citrate Injection Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Sufentanil Citrate Injection Sales Value Share by Country, 2025 VS 2032
7 Sufentanil Citrate Injection Country-level Sales and Value Analysis
  1. 7.1 Global Sufentanil Citrate Injection Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Sufentanil Citrate Injection Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Sufentanil Citrate Injection Sales by Country (2021-2032)
  4. 7.3.1 Global Sufentanil Citrate Injection Sales by Country (2021-2026)
  5. 7.3.2 Global Sufentanil Citrate Injection Sales by Country (2027-2032)
  6. 7.4 Global Sufentanil Citrate Injection Sales Value by Country (2021-2032)
  7. 7.4.1 Global Sufentanil Citrate Injection Sales Value by Country (2021-2026)
  8. 7.4.2 Global Sufentanil Citrate Injection Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Sufentanil Citrate Injection Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Sufentanil Citrate Injection Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Sufentanil Citrate Injection Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Sufentanil Citrate Injection Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Sufentanil Citrate Injection Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Sufentanil Citrate Injection Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Sufentanil Citrate Injection Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Sufentanil Citrate Injection Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Sufentanil Citrate Injection Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Sufentanil Citrate Injection Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Sufentanil Citrate Injection Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Sufentanil Citrate Injection Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Sufentanil Citrate Injection Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Sufentanil Citrate Injection Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Sufentanil Citrate Injection Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Sufentanil Citrate Injection Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Sufentanil Citrate Injection Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Sufentanil Citrate Injection Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Sufentanil Citrate Injection Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Sufentanil Citrate Injection Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Sufentanil Citrate Injection Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Sufentanil Citrate Injection Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Sufentanil Citrate Injection Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Sufentanil Citrate Injection Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Sufentanil Citrate Injection Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Sufentanil Citrate Injection Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Sufentanil Citrate Injection Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Sufentanil Citrate Injection Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Sufentanil Citrate Injection Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Sufentanil Citrate Injection Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Sufentanil Citrate Injection Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Sufentanil Citrate Injection Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Sufentanil Citrate Injection Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Sufentanil Citrate Injection Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Sufentanil Citrate Injection Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Sufentanil Citrate Injection Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Sufentanil Citrate Injection Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Sufentanil Citrate Injection Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Sufentanil Citrate Injection Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Sufentanil Citrate Injection Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Sufentanil Citrate Injection Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Sufentanil Citrate Injection Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Sufentanil Citrate Injection Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Sufentanil Citrate Injection Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Sufentanil Citrate Injection Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Sufentanil Citrate Injection Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Sufentanil Citrate Injection Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Sufentanil Citrate Injection Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Sufentanil Citrate Injection Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Sufentanil Citrate Injection Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Sufentanil Citrate Injection Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Sufentanil Citrate Injection Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Sufentanil Citrate Injection Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Sufentanil Citrate Injection Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Sufentanil Citrate Injection Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Sufentanil Citrate Injection Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Sufentanil Citrate Injection Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Sufentanil Citrate Injection Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Sufentanil Citrate Injection Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Sufentanil Citrate Injection Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Sufentanil Citrate Injection Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Sufentanil Citrate Injection Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Sufentanil Citrate Injection Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Sufentanil Citrate Injection Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Sufentanil Citrate Injection Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Sufentanil Citrate Injection Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Sufentanil Citrate Injection Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Sufentanil Citrate Injection Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Sufentanil Citrate Injection Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Sufentanil Citrate Injection Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Sufentanil Citrate Injection Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Sufentanil Citrate Injection Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Sufentanil Citrate Injection Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Sufentanil Citrate Injection Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Sufentanil Citrate Injection Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Sufentanil Citrate Injection Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Sufentanil Citrate Injection Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Sufentanil Citrate Injection Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Sufentanil Citrate Injection Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Sufentanil Citrate Injection Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Sufentanil Citrate Injection Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Sufentanil Citrate Injection Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Sufentanil Citrate Injection Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Sufentanil Citrate Injection Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Akorn
  2. 8.1.1 Akorn Company Information
  3. 8.1.2 Akorn Business Overview
  4. 8.1.3 Akorn Sufentanil Citrate Injection Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Akorn Sufentanil Citrate Injection Product Portfolio
  6. 8.1.5 Akorn Recent Developments
  7. 8.2 EuroCept B.V.
  8. 8.2.1 EuroCept B.V. Company Information
  9. 8.2.2 EuroCept B.V. Business Overview
  10. 8.2.3 EuroCept B.V. Sufentanil Citrate Injection Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 EuroCept B.V. Sufentanil Citrate Injection Product Portfolio
  12. 8.2.5 EuroCept B.V. Recent Developments
  13. 8.3 hameln pharma gmbh
  14. 8.3.1 hameln pharma gmbh Company Information
  15. 8.3.2 hameln pharma gmbh Business Overview
  16. 8.3.3 hameln pharma gmbh Sufentanil Citrate Injection Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 hameln pharma gmbh Sufentanil Citrate Injection Product Portfolio
  18. 8.3.5 hameln pharma gmbh Recent Developments
  19. 8.4 Hikma Pharmaceuticals USA
  20. 8.4.1 Hikma Pharmaceuticals USA Company Information
  21. 8.4.2 Hikma Pharmaceuticals USA Business Overview
  22. 8.4.3 Hikma Pharmaceuticals USA Sufentanil Citrate Injection Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Hikma Pharmaceuticals USA Sufentanil Citrate Injection Product Portfolio
  24. 8.4.5 Hikma Pharmaceuticals USA Recent Developments
  25. 8.5 IDT Biologika GmBH
  26. 8.5.1 IDT Biologika GmBH Company Information
  27. 8.5.2 IDT Biologika GmBH Business Overview
  28. 8.5.3 IDT Biologika GmBH Sufentanil Citrate Injection Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 IDT Biologika GmBH Sufentanil Citrate Injection Product Portfolio
  30. 8.5.5 IDT Biologika GmBH Recent Developments
  31. 8.6 Pfizer
  32. 8.6.1 Pfizer Company Information
  33. 8.6.2 Pfizer Business Overview
  34. 8.6.3 Pfizer Sufentanil Citrate Injection Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Pfizer Sufentanil Citrate Injection Product Portfolio
  36. 8.6.5 Pfizer Recent Developments
  37. 8.7 Piramal Critical Care Limited
  38. 8.7.1 Piramal Critical Care Limited Company Information
  39. 8.7.2 Piramal Critical Care Limited Business Overview
  40. 8.7.3 Piramal Critical Care Limited Sufentanil Citrate Injection Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Piramal Critical Care Limited Sufentanil Citrate Injection Product Portfolio
  42. 8.7.5 Piramal Critical Care Limited Recent Developments
  43. 8.8 Nhwa Pharmaceutical
  44. 8.8.1 Nhwa Pharmaceutical Company Information
  45. 8.8.2 Nhwa Pharmaceutical Business Overview
  46. 8.8.3 Nhwa Pharmaceutical Sufentanil Citrate Injection Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Nhwa Pharmaceutical Sufentanil Citrate Injection Product Portfolio
  48. 8.8.5 Nhwa Pharmaceutical Recent Developments
  49. 8.9 Sinopharm
  50. 8.9.1 Sinopharm Company Information
  51. 8.9.2 Sinopharm Business Overview
  52. 8.9.3 Sinopharm Sufentanil Citrate Injection Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Sinopharm Sufentanil Citrate Injection Product Portfolio
  54. 8.9.5 Sinopharm Recent Developments
  55. 8.10 Humanwell Pharmaceutical
  56. 8.10.1 Humanwell Pharmaceutical Company Information
  57. 8.10.2 Humanwell Pharmaceutical Business Overview
  58. 8.10.3 Humanwell Pharmaceutical Sufentanil Citrate Injection Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Humanwell Pharmaceutical Sufentanil Citrate Injection Product Portfolio
  60. 8.10.5 Humanwell Pharmaceutical Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Sufentanil Citrate Injection Value Chain Analysis
  2. 9.1.1 Sufentanil Citrate Injection Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Sufentanil Citrate Injection Sales Mode & Process
  6. 9.2 Sufentanil Citrate Injection Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Sufentanil Citrate Injection Distributors
  9. 9.2.3 Sufentanil Citrate Injection Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst